(Q33452058)

English

Phase II trial with oral idarubicin in advanced breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II trial with oral idarubicin in advanced breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

author name string

Lopez M

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Di Lauro L

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Papaldo P

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lazzaro B

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ganzina F

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Di Pietro N

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

39-42

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.1007/bf00172014

0 references

Phase I study of 4-demethoxydaunorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic activity of 4-demethoxydauno-rubicin (idarubicin) in adult acute leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of 4-demethoxydaunorubicin in patients with advanced malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 4-demethoxydaunorubicin with single i.v. doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3457780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00172014

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33452058&oldid=1991716862"